Novo Nordisk CEO Lars Fruergaard Jørgensen weighs in the company's latest obesity drug offering, including its new oral ...

Presenter: Motti Farbstein, Chief Executive & Chief Financial Officer ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Novo Nordisk's Karsten Munk Knudsen is targeting 800 million obese people globally.

Access to healthy food would address the rising rates of obesity, diabetes and heart disease and the psychological issues ...

Novo Nordisk reported turnover from obesity treatments soared by 57 per cent to 65.1 billion Danish kroner last year, largely ...

It revealed that sales of Wegovy, a prescription weight loss injection, surged to 19.9 billion Danish kroner (£2.2 billion) ...

Both high-protein and low-carb diets are effective for weight loss. Consuming more protein may be the most important factor ...

Novo Nordisk said on Wednesday it plan to file its experimental next-generation obesity drug CagriSema for regulatory ...

LONDON/COPENHAGEN (Reuters) -Wegovy maker Novo Nordisk on Wednesday forecast slower sales growth for 2025 than 2024, a blow ...

El Paso, TX (KVIA-TV)-A new definition of obesity, published in the Lancet Diabetes and Endocrinology Journal, proposes a new definition that moves beyond body mass index (BMI). Dr. Jorge Acosta, the ...

Finding it hard to breathe when you lay down is medically called orthopnea. Find a list of potential causes to help narrow down your overall risk here.